Key highlights from Laurus Labs Limited (LAURUSLABS) Q2 FY24 Earnings Concall Q2 FY24 Results Revenue declined 22% year-on-year to INR1,224 crores.. EBITDA
Laurus Labs Limited Q2 FY24 Earnings Conference Call Insights
Categories
Health Care
Syngene International Ltd Q2FY24; 14% rise in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
A Primer on India’s Oldest Pharma Company Ft Alembic Pharmaceuticals
“The company grew in all the business segments with India outperforming the market with 9% growth, Ex US generics grew 46%, API
Procter & Gamble Hygiene and Health Care Ltd Q1FY24; 251% rise in Profits
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods
Alkem Laboratories: Good times ahead?
“This growth was primarily fueled by strong performance of our business in international markets wherein we have crossed Rs.1000 Crores for the
Ruling the Therapeutic Medical Segment Ft Cipla
Our One-India business continued the double-digit trajectory growing at 12% during the quarter led by branded prescription with sustained growth across chronic
Procter & Gamble Health Ltd Q1FY24; 27% fall in Profits
P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals
Panchsheel Organics Ltd Q1FY24; 3% fall in Profits
Panchsheel Organics Ltd is engaged in the business of manufacturing and trading of bulk drugs and intermediates. Financial Results: Panchsheel Organics Ltd
Remedium Lifecare Ltd Q1FY24; 19% fall in Profits
Incorporated in 1988, Remedium Lifecare Ltd is in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products. Financial Results:
Venus Remedies Ltd Q1FY24; 83% fall in Profits
Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the
Zim Laboratories Ltd Q1FY24; 96% fall in Profits
Zim Laboratories Limited is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these
Zota Health Care Ltd Q1FY24; 32% rise in Revenue
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across
Nectar Lifescience Ltd Q1FY24; 53% fall in Profits
Nectar Lifesciences Ltd is primarily engaged in the development, manufacture and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.
Lotus Eye Hospital & Institute Ltd Q1FY24; 1% rise in Profits
Lotus Eye Care Hospital is a Super Speciality eye care hospital offering ophthalmic services with personalised care. Financial Results: Lotus Eye Hospital
Panacea Biotec Ltd Q1FY24; 16% rise in Revenue
Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly listed in
Sakar Healthcare Ltd Q1FY24; 1% fall in Profits
Sakar Healthcare Ltd is engaged in manufacturing of Pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid syrups, dry
Syncom Formulations (India) Ltd Q1FY24; 10% rise in Profits
Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products.
Marksans Pharma Ltd Q1FY24; 17% rise in Profits
Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q1FY24 of
Wockhardt Ltd Q1FY24; 8% rise in Revenue
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
Pfizer Ltd Q1FY24; 185% rise in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Themis Medicare Ltd Q1FY24; 6% rise in Profits
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. Financial Results: